Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial
Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial
Mochihito Suzuki, Y. Hirano, Nobumasa Miyake, Tomonori Kobayakawa et al.
Journal
Arthritis Research & Therapy
Topics
Rheumatoid Arthritis Research and Therapies
article
Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial
Obayashi (Japan) (JP), Ministry of Internal Affairs and Communications (JP), Yazaki (United States) (US), Fujita Health University (JP), Kagawa University (JP), Keio University (JP), Kyoto University (JP), Konan Kosei Hospital (JP), Nagoya University Hospital (JP), Osaka City General Hospital (JP), Tokyo-Kita Medical Center (JP), Ichinomiya Municipal City Hospital (JP), Institute for Rheumatic Diseases (Japan) (JP), Miyake Eye Hospital (JP), Japanese Red Cross Nagoya Daiichi Hospital (JP), University of Miyazaki Hospital (JP), Kagawa University Hospital (JP), Kensei Hospital (JP), Toyota Kosei Hospital (JP), Toyohashi Municipal Hospital (JP), Chukyo Hospital (JP), Nagoya Medical Center (JP), Nagoya University (JP)